C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,367 | +49.6% | 121,165 | +121.2% | 0.00% | – |
| Q2 2023 | $150,610 | -56.5% | 54,767 | -50.3% | 0.00% | – |
| Q1 2023 | $346,040 | +12.1% | 110,204 | +110.6% | 0.00% | – |
| Q4 2022 | $308,800 | -38.7% | 52,339 | -9.0% | 0.00% | – |
| Q3 2022 | $504,000 | +4940.0% | 57,520 | +4290.8% | 0.00% | – |
| Q2 2022 | $10,000 | -99.9% | 1,310 | -99.8% | 0.00% | -100.0% |
| Q1 2022 | $14,539,000 | -30.4% | 599,281 | -7.7% | 0.00% | -50.0% |
| Q4 2021 | $20,897,000 | -27.9% | 648,981 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $28,996,000 | +32.3% | 648,981 | +12.0% | 0.00% | 0.0% |
| Q2 2021 | $21,920,000 | +75.1% | 579,281 | +71.2% | 0.00% | +100.0% |
| Q1 2021 | $12,517,000 | -43.7% | 338,387 | -49.6% | 0.00% | -50.0% |
| Q4 2020 | $22,240,000 | – | 671,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |